Jung-In Ko

Jung-In Ko

Auto-generated profile, based on publicly available information

Jung-In Ko

Department of Emergency Medicine, National Medical Center, Seoul, Korea

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2023 in International Journal of Surgery
Verified
Journal Article
Open access
JKJunsik Kwon
Junsik Kwon
MLMyeonggyun Lee
Myeonggyun Lee
YKYoon Kim
Yoon Kim
JMJonghwan Moon
Jonghwan Moon
YHYo Huh
Yo Huh
KJKyoungwon Jung
Kyoungwon Jung
Background: Trauma is a major cause of mortality, disability, and health care costs worldwide. The establishment of a trauma system is known to solve these problems, but few studies have objectively evaluated the impact of a trauma system on outcomes. Since 2012, South Korea has established a national trauma system based on the implementation of 17 regional trauma centers nationwide and the improvement of the prehospital transfer system. This study aimed to measure the changes in performance and outcome according to the established national trauma system. Material and Methods: In this national cohort-based, retrospective follow-up observational study, the authors calculated the preventable trauma death rate (PTDR) by conducting a multipanel review of patients who died in 2015, 2017, and 2019. Furthermore, the authors constructed a risk-adjusted mortality prediction model of 4 767 876 patients between 2015 and 2019 using the extended-International Classification of Disease Injury Severity Scores to compare outcomes. Results: The PTDR was lower in 2019 than in 2015 (15.7 vs. 30.5, P <0.001) and 2017 (15.7 vs. 19.9%, P<0.001) representing 1247 additional lives saved in 2019 compared to that in 2015. In the risk-adjusted model, total trauma mortality was highest in 2015 at 0.56%, followed by that in 2016 and 2017 (0.50%), 2018 (0.51%), and 2019 (0.48%), revealing a significant decrease in mortality over the years (P<0.001 for trend), representing nearly 800 additional lives saved. The number of deaths for more severe patients with a probability of survival less than 0.25 significantly decreased from 81.50% in 2015 to 66.17% in 2019 (P<0.001). Conclusions: The authors observed a significant reduction in the PTDR and risk-adjusted trauma mortality in the 5-year follow-up since 2015 when the national trauma system was established. These findings could serve as a model for low-income and middle-income countries, where trauma systems are not yet established.

1 June 2018 in Resuscitation
Verified
Journal Article
Closed access
GSGil Joon Suh
Gil Joon Suh
JPJaeheung Park
Jaeheung Park
JLJung Chan Lee
Jung Chan Lee
SNSang Hoon Na
Sang Hoon Na
WKWoon Yong Kwon
Woon Yong Kwon
KYKyoung Min You
Kyoung Min You

1 March 2017 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
SCSeok Ho Choi
Seok Ho Choi
GSGil Joon Suh
Gil Joon Suh
WKWoon Yong Kwon
Woon Yong Kwon
KYUNGSU KIMKYUNGSU KIM
KYUNGSU KIM
MPMin Ji Park
Min Ji Park
JKJeong In Ko
Jeong In Ko
BACKGROUND The aim of this study was to investigate whether a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) inhibitor, apocynin, reduces reactive oxygen species (ROS) production, suppresses the nuclear factor κB (NF-κB) pathway, attenuates lung injury, and improves survival in rat hemorrhagic shock (HS) model. METHODS Blood was drawn from male Sprague–Dawley rats (290–340 g) to maintain a mean arterial pressure of 20–25 mm Hg for 40 minutes. The rats were resuscitated with the drawn blood, and a vehicle (HS), a low dose of apocynin (20 mg/kg, LD-Apo), or a high dose of apocynin (40 mg/kg, HD-Apo) was administered intraperitoneally. The survival of the rats was observed for 72 hours. Then, a separated set of rats was euthanized at 6 hours post-HS induction. We measured gp91-phox (Nox2) expression, Nox activity, cytoplasmic phosphorylated inhibitor κB-α (p-IκB-α) expression, NF-κB p65 DNA-binding activity, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) gene expressions, malondialdehyde (MDA) level, myeloperoxidase (MPO) activity, and histological damage in the lung tissues. RESULTS The survival rates of the sham, HS, HS + LD-Apo, and HS + HD-Apo groups were 100% (5/5), 30% (3/10), 40% (4/10), and 70% (7/10), respectively. A high dose of apocynin decreased gp91-phox expression, Nox activity, and MDA level in the lung tissues during HS and resuscitation. It also decreased p-IκB-α expression, NF-κB p65 DNA-binding activity, TNF-α and IL-6 gene expressions, and MPO activity in the lung tissues and attenuated histological lung injuries. However, a low dose of apocynin failed to show these benefits. CONCLUSIONS The administration of a high dose of apocynin inhibited Nox2 expression and Nox activity, reduced lipid peroxidation, suppressed the NF-κB pathway and subsequent pro-inflammatory cytokines transcription in the lung tissues, and attenuated lung injury during HS and resuscitation in rats.

1 October 2018 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
HKHyeongkyu Kwak
Hyeongkyu Kwak
GSGil Joon Suh
Gil Joon Suh
TKTaegyun Kim
Taegyun Kim
WKWoon Yong Kwon
Woon Yong Kwon
KYUNGSU KIMKYUNGSU KIM
KYUNGSU KIM
SSSo Mi Shin
So Mi Shin

1 August 2017 in Resuscitation
Verified
Journal Article
Closed access
KYKyoung Min You
Kyoung Min You
GSGil Joon Suh
Gil Joon Suh
WKWoon Yong Kwon
Woon Yong Kwon
KYUNGSU KIMKYUNGSU KIM
KYUNGSU KIM
SKSANG BAE KO
SANG BAE KO
JKJung-In Ko
Jung-In Ko

1 October 2017 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
SKSaee Byel Kang
Saee Byel Kang
KYUNGSU KIMKYUNGSU KIM
KYUNGSU KIM
GSGil Joon Suh
Gil Joon Suh
WKWoon Yong Kwon
Woon Yong Kwon
KYKyoung Min You
Kyoung Min You
TKTaegyun Kim
Taegyun Kim